| First Author | Choi MG | Year | 2018 |
| Journal | PLoS One | Volume | 13 |
| Issue | 4 | Pages | e0195339 |
| PubMed ID | 29608598 | Mgi Jnum | J:261048 |
| Mgi Id | MGI:6151022 | Doi | 10.1371/journal.pone.0195339 |
| Citation | Choi MG, et al. (2018) Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide. PLoS One 13(4):e0195339 |
| abstractText | alpha-Synuclein (alpha-syn) is a major component of Lewy bodies found in synucleinopathies including Parkinson''s disease (PD) and Dementia with Lewy Bodies (DLB). Under the pathological conditions, alpha-syn tends to generate a diverse form of aggregates showing toxicity to neuronal cells and able to transmit across cells. However, mechanisms by which alpha-syn aggregates affect cytotoxicity in neurons have not been fully elucidated. Here we report that alpha-syn aggregates preferentially sequester specific synaptic proteins such as vesicle-associated membrane protein 2 (VAMP2) and synaptosomal-associated protein 25 (SNAP25) through direct binding which is resistant to SDS. The sequestration effect of alpha-syn aggregates was shown in a cell-free system, cultured primary neurons, and PD mouse model. Furthermore, we identified a specific blocking peptide derived from VAMP2 which partially inhibited the sequestration by alpha-syn aggregates and contributed to reduced neurotoxicity. These results provide a mechanism of neurotoxicity mediated by alpha-syn aggregates and suggest that the blocking peptide interfering with the pathological role of alpha-syn aggregates could be useful for designing a potential therapeutic drug for the treatment of PD. |
